Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QL1706, CAPOX, and Radiotherapy in Rectal Cancer With Liver Metastases
NCT06787183Phase 2Recruiting
- Sponsor
- Fujian Medical University Cancer Hospital
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- Bispecific Antibodies, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of QL1706 in rectal cancer, sponsored by Fujian Medical University Cancer Hospital. Started Dec 2025; status: recruiting.
02
Drugs
QL1706
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT06787183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06787183.